Back to Corient Private Wealth LP Corient Private Wealth LP

NAUTNAUT
Showing 8 of 13 quarters

Position history for Corient Private Wealth LPCorient Private Wealth LP's holdings in NAUTILUS BIOTECHNOLOGY INC

Corient Private Wealth LP holds 164,788 shares of NAUT (NAUTILUS BIOTECHNOLOGY INC), worth $308,154 as of 2026-Q2. The position was increased (+43.6% shares). NAUT represents 0.0% of Corient Private Wealth LP's portfolio.

Current Value

$308,154

Current Shares

164,788

Total Value Change

+$178,906

Total Shares Change

+119,438

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
164,788
+43.6%
$308,1540.0%$1.87
32
2026-Q1
Decreased
114,788
-50.0%
$445,3770.0%$2.41
0
2025-Q4
Decreased
229,576
-28.1%
$447,6740.0%$1.91
0
2025-Q3
Decreased
319,140
-26.7%
$269,6410.0%$0.80
0
2025-Q2
Increased
435,350
+860.0%
$315,5860.0%$0.69
38
2025-Q1
Unchanged
45,350
0.0%
$39,0470.0%$0.89
0
2024-Q4
Unchanged
45,350
0.0%
$76,1880.0%$1.67
0
2024-Q3
Unchanged
45,350
0.0%
$129,2480.0%$2.91
0

Other major holders of NAUT: RA CAPITAL MANAGEMENT, L.P., Alyeska Investment Group, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used